Prime Medicine, Inc.·4

Apr 4, 8:23 PM ET

Goldwasser Meredith 4

4 · Prime Medicine, Inc. · Filed Apr 4, 2023

Insider Transaction Report

Form 4
Period: 2023-03-31
Goldwasser Meredith
SVP, Strategy & Corporate Ops.
Transactions
  • Award

    Stock Option (right to buy)

    2023-03-31+90,49890,498 total
    Exercise: $12.30Exp: 2033-03-31Common Stock (90,498 underlying)
Footnotes (1)
  • [F1]1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 31, 2023, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file
  • 4
    wf-form4_168065419207928.xmlPrimary

    FORM 4